Skip to content

Effect of hydroxyethyl starch on renal handling of salt and water, blood pressure-regulating hormones, proteins and circulatory system of patients undergoing prostate removal

Effect of hydroxyethyl starch on renal handling of sodium and water, vasoactive hormones,biomarkers and the circulatory system in patients undergoing radical prostatectomy - Hydroxyethyl starch and renal function after radical prostatectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-004274-28-DK
Enrollment
40
Registered
2011-09-09
Start date
2011-09-21
Completion date
Unknown
Last updated
2016-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing radical prostatectomy in generel anesthesia MedDRA version: 14.1 Level: LLT Classification code 10007113 Term: Cancer of prostate System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)

Interventions

Sponsors

Erling Bjerregaard Pedersen, Medicinsk forskningsafsnit, Regionshospitalet Holstebro
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: - Age > 18 years - Males - Indication for radical prostatectomy Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - Blooddonation within the last month - Lack of wish to participate - eGFR< 15ml/min

Design outcomes

Primary

MeasureTime frame
Main Objective: The objective is for elective laparoscopic nephrectomy to measure the effect of hydroxyethyl starch on biomarkers of nephrotoxicity (U-Alb, u- NGAL, u-Kim 1, u-FABP) ;Secondary Objective: Secondarily to measure the effect of hydroxyethyl starch on the renal tubular transport of sodium and water (FENa, u-ENaCß, CH2O, u-AQP2, u-NCC, u-NK2CC), vasoactive hormones (PRC, p-Ang-II, p -Aldo, p-ANP, P-GDP, p-AVP, p-Endot), central hemodynamics (SBP, DBP, heart rate) and on the glycocalyx layer of the endothelium (syndecan-1) during elective radical prostatectomy;Primary end point(s): u- NGAL

Secondary

MeasureTime frame
Secondary end point(s): PRC, p-Ang-II, p-Aldo, p-ANP, p-BNP, p-AVP, p-Endot, CH2O, u-AQP2, FENa u- EnaCß, u-Alb, u-Kim 1, u-FABP, u-NCC, u-NK2CC, heart rate, SBP, DBP and Syndecan-1

Countries

Denmark

Contacts

Public ContactMedicinsk forskningsafsnit

Regionshospitalet Holstebro

annekanc@rm.dk+457843 6586

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026